Affiner la recherche

Vous avez cherché

  • Livres (18)

  • Neuf (18)

à

Fourchette de prix personnalisée (EUR)

à

David h crean (18 résultats)

  • Langue : anglais

    Edité par David Crean, 2026

    9798952851153

    • Couverture souple

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 33,80

    EUR 2,73 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 39,43

    EUR 2,73 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple

    Vendeur : Home-set, Mannheim, AllemagneHome-set

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 71,88

    EUR 49,90 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Softcover/Taschenbuch. Etat : Neu. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." Sprache: Englisch Gewicht in Gramm: 351.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide

    Vendeur : Home-set, Mannheim, AllemagneHome-set

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 79,75

    EUR 49,90 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Gebundene Ausgabe. Etat : Neu. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." Sprache: Englisch Gewicht in Gramm: 412.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 36,60

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Paperback. Etat : new. Paperback. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 37,88

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 34,92

    EUR 4,98 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 42,24

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 45,27

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 41,36

    EUR 4,98 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 49,62

    EUR 33,72 expédition 
    Expédition depuis Australie vers Etats-Unis

    Quantité disponible : 1 disponible

    Paperback. Etat : new. Paperback. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 39,48

    EUR 44,33 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible

    Paperback. Etat : new. Paperback. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 46,26

    EUR 44,33 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 58,94

    EUR 33,72 expédition 
    Expédition depuis Australie vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. What separates the life sciences CEOs who build enduring companies from those who don't?In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value."The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom." This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 57,27

    EUR 35,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - What separates the life sciences CEOs who build enduring companies from those who don't In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value.'The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom.'.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 58,43

    EUR 35,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - What separates the life sciences CEOs who build enduring companies from those who don't In life sciences, the answer is rarely pedigree, network, or technical knowledge alone. It is the ability to speak two languages simultaneously, the language of science and the language of capital, and to be trusted in both rooms.Dual Fluency is the practitioner's guide to mastering that rare combination. Drawing on more than thirty years spanning M&A, licensing, partnering, and capital raises across numerous therapeutic disciplines, David H. Crean, PhD, MBA offers an unfiltered view of how transformative companies get built and sold and why so many promising ones quietly fall apart.This is not a textbook. It is not a retrospective written from the comfort of retirement. It is the operating thesis of a working professional who has sat on both sides of the table inside large pharma, alongside venture and private equity capital providers, and at the advisory helm of investment banking for some of the sector's most complex transactions.For founders, CEOs, business development executives, scientists entering industry, finance executives, and investors navigating the life sciences ecosystem, Dual Fluency delivers what no MBA curriculum and no conference panel ever could: the unvarnished logic of how science becomes strategy, and how strategy becomes value.'The most powerful life sciences leaders are those who can move fluidly between scientific truth and financial reality and build organizations that do the same. Leadership in this sector is not just about managing people. It is about managing translation: between data and capital, between discovery and deal, between boardroom and boardroom.'.…

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851153

    • Couverture souple
    • impression à la demande

    Vendeur : preigu, Osnabrück, Allemagnepreigu

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 65,30

    EUR 70,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 5 disponibles

    Taschenbuch. Etat : Neu. Dual Fluency | The Language of Science and Capital in Life Sciences | David H. Crean | Taschenbuch | Englisch | 2026 | David H. Crean | EAN 9798952851153 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. …

  • Langue : anglais

    Edité par David H. Crean, 2026

    9798952851160

    • Couverture rigide
    • impression à la demande

    Vendeur : preigu, Osnabrück, Allemagnepreigu

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 71,90

    EUR 70,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 5 disponibles

    Buch. Etat : Neu. Dual Fluency | The Language of Science and Capital in Life Sciences | David H. Crean | Buch | Englisch | 2026 | David H. Crean | EAN 9798952851160 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…